Colchicine Use for Primary Prevention of Coronary Artery Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 6792 participants.

Also called NCT05175274

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 6,792 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05175274
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT05175274. Randomized; double masking; primary purpose prevention. Start 2022-12-06 (anticipated); primary completion 2027-03-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine Use for Primary Prevention of Coronary Artery Disease
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Qingdao Central Hospital (class: other)
Collaborator
Qingdao Municipal Hospital (class: other)

Record details

Record id
cardio:ct-nct05175274
Content hash
619cfe0f0a8947d63c715efda2bebf8f14abf33d7f3871b5c63337de923c95d6